Long-term outcome of phenobarbital treatment for epilepsy in rural China: A prospective cohort study

Epilepsia

Volumn 54, Issue 3, 2013, Pages 537-542

  Kwan, Patrick ^a,b   Wang, Wenzhi ^c   Wu, Jianzhong ^c   Li, Shichuo ^d   Yang, Hongchao ^d   Ding, Ding ^e   Hong, Zhen ^e   Dai, Xiuying ^f   Yang, Bing ^g   Wang, Taiping ^h   Yuan, Chenglin ⁱ   Ma, Guangyu ^j   De Boer, Hanneke M ^k   Sander, Josemir W ^k,l,m  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d China Association Against Epilepsy   (China)

^e FUDAN UNIVERSITY   (China)

^f NINGXIA MEDICAL UNIVERSITY   (China)

^g Jiaozuo People's Hospital   (China)

^h Zezhou County Hospital   (China)

ⁱ CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^j Universal Love Hospital   (China)

^k STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m EPILEPSY SOCIETY   (United Kingdom)

more..

Author keywords

China; Epilepsy; Outcome; Phenobarbital

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CHINA; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INTERVIEW; LETHARGY; MAJOR CLINICAL STUDY; MALAISE; MALE; MEMORY DISORDER; MENTAL DISEASE; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RURAL AREA; SCHOOL CHILD; SEIZURE; SOMNOLENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHENOBARBITAL; PROSPECTIVE STUDIES; RURAL POPULATION; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874708933     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12022     Document Type: Article

References (19)

1. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ, for the Levetiracetam Monotherapy Study Group. (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68: 402-408.
2. Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P,. (2012) Patterns of treatment response in newly diagnosed epilepsy. Neurology 78: 1548-1554.
3. Ding D, Hong Z, Chen GS, Dai XY, Wu JZ, Wang WZ, De Boer HM, Sander JW, Prilipko L, Chisholm D,. (2008) Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project. Epilepsia 49: 535-539.
4. Ding D, Zhang Q, Zhou D, Lin W, Wu Q, Sun J, Zhao Q, Yu P, Wang W, Wu J, Bell GS, Kwan P, de Boer H, Li S, Thompson PJ, Hong Z, Sander JW,. (2012 a) Cognitive and mood effects of phenobarbital treatment in people with epilepsy in rural China: a prospective study. J Neurol Neurosurg Psychiatry Jul 31, Doi: 10.1136/jnnp-2012-303042. [Epub ahead of print].
5. Ding D, Wang W, Wu J, Hong Z, Yang H, Li S, Dai X, Yang B, Wang T, Yuan C, Ma G, Bell GS, Kwan P, de Boer HM, Sander JW,. (2012b) Premature mortality risk in people with convulsive epilepsy: Long follow-up of a cohort in Rural China. Epilepsia (In press).
6. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T,. (2006) ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47: 1094-1120.
7. Hu Y, Lu Y, Yu W, Shen D, Xiao Z, Xi Z, Wang X,. (2010) Long-term retention rate of topiramate as initial monotherapy in Chinese patients with newly diagnosed epilepsy: a prospective, observational study. Epilepsy Res 90: 278-284.
8. Kale R,. (1997) Bringing epilepsy out of the shadows. BMJ 315: 2-3.
9. Kwan P, Brodie MJ,. (2001) Effectiveness of first antiepileptic drug. Epilepsia 42: 1255-1260.
10. Kwan P, Brodie MJ,. (2004) Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 45: 1141-1149.
11. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD,. (2000) Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 48: 833-841.
12. Mbuba CK, Ngugi AK, Newton CR, Carter JA,. (2008) The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 49: 1491-1503.
13. Mohanraj R, Brodie MJ,. (2006) Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 13: 277-282.
14. Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, Yuan CL, Scott RA, Prilipko LL, de Boer HM, Sander JW,. (2003) The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 60: 1544-1545.
15. Wang WZ, Wu JZ, Ma GY, Dai XY, Yang B, Wang TP, Yuan CL, Hong Z, Bell GS, Prilipko L, de Boer HM, Sander JW,. (2006) Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol 5: 46-52.
16. Wang WZ, Wu JZ, Dai XY, Ma GY, Yang B, Wang TP, Yuan CL, Hong Z, Kwan P, Bell GS, Prilipko L, de Boer HM, Sander JW,. (2008) Global Campaign Against Epilepsy: demonstration project in the PR of China: outcome assessment. Bull World Health Organ 86: 964-969.
17. World Health Organization. (2009) Epilepsy management at primary health level in rural China: WHO/ILAE/IBE. A Global Campaign Against Epilepsy Demonstration Project.
18. World Health Organization. (2012) Standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) for management of convulsive epilepsy in adults and children. http://www.who.int/mental-health/ mhgap/evidence/epilepsy/q7/en/index. html (Accessed 21 April 2012).
19. Zhang LL, Zeng LN, Li YP,. (2011) Side effects of phenobarbital in epilepsy: a systematic review. Epileptic Disord 13: 349-365.